4//SEC Filing
Drechsler Andrew T 4
Accession 0001493152-20-015601
CIK 0001695357other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 7:01 PM ET
Size
5.0 KB
Accession
0001493152-20-015601
Insider Transaction Report
Form 4
Drechsler Andrew T
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-08-13$13.01/sh+1,750$22,768→ 18,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.02, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
Documents
Issuer
Provention Bio, Inc.
CIK 0001695357
Entity typeother
Related Parties
1- filerCIK 0001324734
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 7:01 PM ET
- Size
- 5.0 KB